Morgan Stanley Downgrades Core Laboratories to Underweight, Announces $20 Price Target
Morgan Stanley analyst Connor Lynagh downgrades Core Laboratories (NYSE:CLB) from Equal-Weight to Underweight and announces $20 price target.
Morgan Stanley Maintains Equal-Weight on Core Laboratories, Lowers Price Target to $20
Morgan Stanley analyst Connor Lynagh maintains Core Laboratories (NYSE:CLB) with a Equal-Weight and lowers the price target from $22 to $20.
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 326 stocks hit new 52-week lows.
Earnings Scheduled For April 27, 2022
Companies Reporting Before The Bell
• Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.